Otsuka’s kidney therapy gets accelerated FDA approval
Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and Drug Administration...
Approval
IceCure ProSense Receives Swissmedic Approval for Breast Cancer
This latest approval further broadens global access to ProSense® and supports IceCure's commercial momentum following the U.S. Food and Drug...
Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval
Cash truly is king. On Monday, shares in Novo Nordisk jumped 4% after the drugmaker announced that US customers who...
HLB Reapply for Liver Cancer Drug Approval from FDA
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas
A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full...
HLB Fails to Receive US FDA Approval for Rivoceranib Liver Cancer Treatment
The logo of HLB HLB has failed to secure approval from the U.S. Food and Drug...
